Prospective Bidirectional Associations Between Core Schemas, Attenuated Psychotic Symptoms, and Functioning in Youth at Clinical High Risk for Psychosis
Objective: Cognitive models of psychosis implicate maladaptive core schemas in the development and emergence of psychotic symptoms, but no study has tested temporal dynamics between schemas and psychotic symptoms in a large sample of clinical high-risk (CHR) youth. Given their sizable role in cognitive behavioral therapies, the first-line treatment for CHR youth, core schemas may be key to both symptom development and treatment in this population. Methods: Participants were 578 CHR individuals from the second North American Prodrome Longitudinal Study (NAPLS-2) assessed across five timepoints. Time-lagged mixed-effects models tested forward and reverse paths for each Brief Core Schema Scales subscale with both psychotic symptom and functioning changes, controlling for autoregressive effects, time-varying depression, and linear time. Results: Twenty of 36 schema outcome pairs showed significant prospective associations. Negative-other schemas were prospectively associated with worsening across nearly all psychosis symptom and functioning domains. Suspiciousness exhibited bidirectional associations with all four schema subscales. Grandiose ideas were uniquely prospectively associated with positive-self and negative-other schemas. Positive schemas were prospectively associated with decreases in suspiciousness, negative symptoms, and improvements in functioning. Effects were largely independent of depressive symptoms and robust across sensitivity analyses, with partial attenuation of self-schema effects on suspiciousness. Conclusions: Core schemas were prospectively associated with psychosis symptom and functioning change in CHR youth, with symptom-domain specificity and bidirectionality. These findings extend cognitive models of psychosis into CHR syndromes and highlight schemas as potentially modifiable treatment targets to improve outcomes in this population.
Sex-related differences in the clinical presentation and course of schizophrenia spectrum disorders are increasingly recognized, yet it remains unclear whether biological sex moderates response to psychological interventions. Metacognitive Training for psychosis is an evidence-based psychological intervention targeting...
M. Lamarca, Adrien Goncalves, Steffen Moritz et al.· PLoS ONE· 0 citations
BACKGROUND: Clinical high risk (CHR) for psychosis is characterized by substantial heterogeneity in symptoms, functioning, and outcomes. Although distributed resting-state functional connectivity (RSFC) abnormalities have been reported, it remains unclear whether this heterogeneity can be organized into consistent mult...
J. Feng, S. Genon, S. Eickhoff et al.· medRxiv· 0 citations
A significantly impaired neurocognitive profile in early childhood confers risk for detrimental clinical and functional outcomes in middle childhood beyond that which can be attributed to pre-existing clinical and functional states and constitutes a cross-diagnostic, neurodevelopmental risk marker in these FHR-groups.
N. Hemager, J. Jepsen, A. Greve et al.· Journal of Child Psychology...· 0 citations
Abstract Background Childhood trauma increases the risk for psychosis. However, mechanisms underlying this relationship remain unclear. In the present study, we aimed to investigate whether negative cognitive self-schemas or basic self-disturbance mediate the association between childhood trauma subtypes (abuse and neg...
A. Jelsma, Justine de With, M. van der Pluijm et al.· Psychological Medicine· 0 citations
Symptoms and psychosocial factors interact dynamically across affective and psychotic disorders, yet longitudinal evidence remains limited. Building on the network theory of psychopathology, this study conceptualizes mental disorders as systems shaped by symptom-environment interactions. Using data from a two-site Germ...
Rui Tan, F. Stein, L. Teutenberg et al.· European Archives of Psychia...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.